Annotation Detail for LILRA2

Basic Information
Top
| Desease ID | Desease Name |
|---|
| 2146 | Lupus erythematosus |
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D008628 |
Mercury |
Mercury results in decreased expression of LILRA2 mRNA | decreases expression | 16823088
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D001321 |
Autistic Disorder |
|
Mercury |
2.75 | 17497416 |
| MESH:D001327 |
Autoimmune Diseases |
|
Mercury |
5.78 | 16634805 |
| MESH:D002311 |
Cardiomyopathy, Dilated |
|
Mercury |
3.59 | 10334427 |
| MESH:D017449 |
Dermatitis, Allergic Contact |
|
Mercury |
4.69 | 16823706 |
| MESH:D007674 |
Kidney Diseases |
|
Mercury |
3.83 | 17934191 |
| Pathway ID |
Pathway Name |
|---|
| KEGG:04380 |
Osteoclast differentiation |
PharmGKB Accession:PA30377
| Releated disease ID |
Related disease Name |
| PA446155 | Precursor Cell Lymphoblastic Leukemia-Lymphoma |